Table 4.
Univariate and multivariate analysis of relation of confounders to ACR group
| Univariate analysis | P-value | Multivariable analysis | P-value | |
|---|---|---|---|---|
| Odds ratio (95% CI) | Odds ratio (95% CI) | |||
| Confounders | ||||
| Gender | 0.71 (0.18–2.87) | 0.64 | 0.32 (0.02–4.28) | 0.39 |
| Diabetes | 1.33 (0.23–7.80) | 0.75 | 1.22 (0.09–16.77) | 0.88 |
| Ischaemic transport damage | 1.94 (0.94–4.02) | 0.07 | 3.02 (0.77–11.86) | 0.11 |
| Weight | 1.00 (0.97–1.03) | 0.96 | 1.02 (0.94–1.11) | 0.62 |
| CAV | 0.54 (0.08–3.40) | 0.51 | 0.16 (0.01–3.04) | 0.23 |
| SBP | 0.98 (0.94–1.02) | 0.33 | 0.97 (0.91–1.03) | 0.30 |
| DBP | 1.01 (0.94–1.09) | 0.78 | 1.09 (0.94–1.26) | 0.26 |
| HR | 1.03 (0.97–1.10) | 0.35 | 1.04 (0.92–1.17) | 0.52 |
| LV mass | 1.00 (0.99–1.01) | 0.93 | 1.00 (0.97–1.03) | 0.88 |
| LVEF | 1.02 (0.91–1.13) | 0.74 | 0.98 (0.85–1.13) | 0.80 |
| LV and RV long-axis function | ||||
| LV-GLS | 1.55 (1.08–2.22) | <0.05* | 4.11 (1.03–16.3) | <0.05* |
| TAPSE | 0.70 (0.50–0.98) | <0.05* | 0.23 (0.07–0.81) | <0.05* |
CAV, coronary allograft vasculopathy; SBP, systolic blood pressure; DBP, diastolic blood pressure; HR, heart rate; LV, left ventricle; LVEF, left ventricular ejection fraction; GLS, global longitudinal strain; TAPSE, tricuspid annular plane systolic excursion.
*P < 0.05.